PD-1 and PD-L1 expression in molecularly selected non-small-cell lung cancer patients
about
Immune checkpoint inhibitors: the new frontier in non-small-cell lung cancer treatmentTargeted therapies and immunotherapy in non-small-cell lung cancerPD-L1 biomarker testing for non-small cell lung cancer: truth or fiction?Kirsten Ras* oncogene: Significance of its discovery in human cancer researchPD-1/PD-L1 blockades in non-small-cell lung cancer therapyInterplay between Cellular and Molecular Inflammatory Mediators in Lung CancerIntegrating the molecular background of targeted therapy and immunotherapy in lung cancer: a way to explore the impact of mutational landscape on tumor immunogenicityMutation status concordance between primary lesions and metastatic sites of advanced non-small-cell lung cancer and the impact of mutation testing methodologies: a literature reviewDevelopment of PD-1/PD-L1 Pathway in Tumor Immune Microenvironment and Treatment for Non-Small Cell Lung CancerUnderstanding the function and dysfunction of the immune system in lung cancer: the role of immune checkpointsPredictive biomarkers in precision medicine and drug development against lung cancerTrial Watch: Immunomodulatory monoclonal antibodies for oncological indicationsPD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined SubgroupsPrognostic impact of programmed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor-infiltrating lymphocytes in ovarian high grade serous carcinomaPrognostic value of programmed cell death-ligand 1 expression in patients with non-small-cell lung cancer: evidence from an updated meta-analysis.Antagonizing programmed death-1 and programmed death ligand-1 as a therapeutic approach for gastric cancerImmune Responses to Epidermal Growth Factor Receptor (EGFR) and Their Application for Cancer TreatmentFocus on Nivolumab in NSCLCMetastatic squamous cell non-small-cell lung cancer (NSCLC): disrupting the drug treatment paradigm with immunotherapiesClinical Research Progress of Anti PD-1/PD-L1 Monoclonal Antibody in the Treatment of Lung CancerElevated Cellular PD1/PD-L1 Expression Confers Acquired Resistance to Cisplatin in Small Cell Lung Cancer CellsBilateral Anterior Uveitis Associated with Nivolumab Therapy.Comparing two assays for clinical genomic profiling: the devil is in the data.Evaluation of PD-L1 Expression in Tumor Tissue of Patients with Lung Carcinoma and Correlation with Clinical and Demographic Data.Expression of programmed death-1 ligand (PD-L1) in tumor-infiltrating lymphocytes is associated with favorable spinal chordoma prognosis.The correlation between programmed death-ligand 1 expression and driver gene mutations in NSCLC.PD-L1 expression and its relationship with oncogenic drivers in non-small cell lung cancer (NSCLC)Classifying Cancers Based on T-cell Infiltration and PD-L1.PD-L1 expression associated with better response to EGFR tyrosine kinase inhibitorsCirculating PD-L1 in NSCLC patients and the correlation between the level of PD-L1 expression and the clinical characteristics.The association between PD-L1 and EGFR status and the prognostic value of PD-L1 in advanced non-small cell lung cancer patients treated with EGFR-TKIsPD-L1 and Tumor Infiltrating Lymphocytes as Prognostic Markers in Resected NSCLC.Immune-Modulation by Epidermal Growth Factor Receptor Inhibitors: Implication on Anti-Tumor Immunity in Lung CancerLung cancer: Biology and treatment options.PD-L1 expression and prognostic impact in glioblastoma.PD-L1 is remarkably over-expressed in EBV-associated pulmonary lymphoepithelioma-like carcinoma and related to poor disease-free survivalHigh PD-L1 expression was associated with poor prognosis in 870 Chinese patients with breast cancer.PD-L1 Expression and Survival among Patients with Advanced Non-Small Cell Lung Cancer Treated with ChemotherapyEML4-ALK enhances programmed cell death-ligand 1 expression in pulmonary adenocarcinoma via hypoxia-inducible factor (HIF)-1α and STAT3Expression of PD-L1 in triple-negative breast cancer based on different immunohistochemical antibodies.
P2860
Q26738359-48DD5173-F6E6-41F8-8649-DEAD0255FB24Q26738986-9B43F58B-232B-4DBB-AE4C-E3983B44504AQ26741101-1D30AC5D-C05F-4945-8A00-13E29D94F99AQ26751212-58B15241-6BA6-43C6-BEA7-1FD206AAC7ADQ26765024-3B0E216D-C275-40A9-B3D6-61F3BA8178CCQ26768652-FF34B5AB-BE16-4345-BCD9-7CEEAEA81265Q26769744-6DC36B8B-0DE3-4831-A68A-0C404F52F5D5Q26785713-A1BBC86B-8482-4A44-B932-B480DEB1B222Q26798047-545C6FA7-9040-438B-8F04-7068D3118B4FQ26801551-7410B7EC-6785-466D-BE86-0D6C5A4BD23BQ26824536-8A0D6427-6C79-4AFE-8B5E-431619FF4A84Q26996518-1F5D206E-B5C2-4F13-A971-D0AECBB861D3Q27853205-BDB5AEA3-31D0-48A2-A155-B5827392B774Q27853285-2DC69C90-72A1-4792-8CD9-308E80658D58Q27853291-0AF378C4-896F-4669-A735-76AF4A510F37Q28066532-BF28F8F7-48DF-4062-97E1-FAC46973E89FQ28069424-93031DCB-B820-4452-A65A-75B0B03CC437Q28073759-6A7F638A-4CCF-4A50-AD0D-CDA933AA857CQ28083840-35951ECB-A8EA-47DF-93AC-F4A3F6CB5F96Q28084766-B8FCF33F-7D8B-48BB-AC41-AD27FE08FFD3Q28553961-9645322B-7125-4D40-97ED-F7FD28578B9CQ30275991-3FEB804A-74B8-4976-B754-5008CB91F22BQ30992076-E1FD3E42-1D41-48DE-B4D1-EA366E995932Q31137039-6BD0D99C-DCCF-4B8A-BFB5-CA9B76688C26Q33276164-73ADBCB7-AA9B-497F-831A-E9B0E5F65E92Q33618747-4B0D9E40-65C1-49D6-8688-77F4874DD5C8Q33688849-9B0555A8-AFDA-4DD9-8A49-0A69E424FDA8Q35674821-44AF190C-98F6-4CCA-AE3C-2031D6DD6CC5Q35824122-EC862E74-102A-44EA-AFAE-1A8ABE2D9BA0Q35879427-3A0223ED-FB21-4739-9C63-CB2CE323EDB3Q35987305-A1FC57C5-79FD-4A30-903E-5D17E9407A97Q35996819-AC80492A-EDF0-4492-AF84-7A0DE3DD14E4Q36088496-879FEC52-CF8B-4202-B272-C8B71B669988Q36328370-27F64983-936C-4A0D-8ACF-46E4C09B10F2Q36493843-8919B4E3-1033-4786-B631-AC788571BAA0Q36545054-0DAA027C-44F6-4CCB-A24F-8B2A89BFAAF7Q36545353-F4230DE0-01FB-4BDC-8C2E-33C3FED83546Q36707123-CD6EB526-AFC8-4A0A-AB99-A95733A2E0FEQ36821217-AEACDD1F-A3BF-4E8C-B65D-6B7CC6A12BEBQ36994508-309F939E-563E-4CB3-B4CF-3A2F83389F9E
P2860
PD-1 and PD-L1 expression in molecularly selected non-small-cell lung cancer patients
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
PD-1 and PD-L1 expression in molecularly selected non-small-cell lung cancer patients
@ast
PD-1 and PD-L1 expression in molecularly selected non-small-cell lung cancer patients
@en
type
label
PD-1 and PD-L1 expression in molecularly selected non-small-cell lung cancer patients
@ast
PD-1 and PD-L1 expression in molecularly selected non-small-cell lung cancer patients
@en
prefLabel
PD-1 and PD-L1 expression in molecularly selected non-small-cell lung cancer patients
@ast
PD-1 and PD-L1 expression in molecularly selected non-small-cell lung cancer patients
@en
P2093
P2860
P50
P356
P1476
PD-1 and PD-L1 expression in molecularly selected non-small-cell lung cancer patients
@en
P2093
A D'Incecco
L Terracciano
P2860
P2888
P304
P356
10.1038/BJC.2014.555
P407
P577
2014-10-28T00:00:00Z